vs

Side-by-side financial comparison of Infobird Co., Ltd (IFBD) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

Infobird Co., Ltd is the larger business by last-quarter revenue ($3.4M vs $1.8M, roughly 2.0× INVO Fertility, Inc.). Infobird Co., Ltd runs the higher net margin — -46.7% vs -150.5%, a 103.8% gap on every dollar of revenue. On growth, Infobird Co., Ltd posted the faster year-over-year revenue change (17118.0% vs 22.6%).

Infobird Co., Ltd. is a China-based technology firm specializing in AI-powered customer engagement and smart customer service solutions. It serves clients across e-commerce, finance, telecommunications, and internet service sectors, offering cloud-based SaaS tools, intelligent call center systems, and customized digital operation support to help enterprises boost service efficiency and customer satisfaction.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

IFBD vs IVF — Head-to-Head

Bigger by revenue
IFBD
IFBD
2.0× larger
IFBD
$3.4M
$1.8M
IVF
Growing faster (revenue YoY)
IFBD
IFBD
+17095.4% gap
IFBD
17118.0%
22.6%
IVF
Higher net margin
IFBD
IFBD
103.8% more per $
IFBD
-46.7%
-150.5%
IVF

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
IFBD
IFBD
IVF
IVF
Revenue
$3.4M
$1.8M
Net Profit
$-1.6M
$-2.6M
Gross Margin
37.2%
Operating Margin
-31.8%
-93.1%
Net Margin
-46.7%
-150.5%
Revenue YoY
17118.0%
22.6%
Net Profit YoY
-98.1%
-62.2%
EPS (diluted)
$-0.41
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IFBD
IFBD
IVF
IVF
Q3 25
$1.8M
Q2 25
$3.4M
$1.9M
Q1 25
$1.6M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$1.8M
Q1 24
$1.6M
Q4 23
$1.4M
Net Profit
IFBD
IFBD
IVF
IVF
Q3 25
$-2.6M
Q2 25
$-1.6M
$-5.3M
Q1 25
$-17.4M
Q4 24
$-3.6M
Q3 24
$-1.6M
Q2 24
$-2.2M
Q1 24
$-1.6M
Q4 23
$-2.0M
Gross Margin
IFBD
IFBD
IVF
IVF
Q3 25
Q2 25
37.2%
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Q4 23
33.0%
Operating Margin
IFBD
IFBD
IVF
IVF
Q3 25
-93.1%
Q2 25
-31.8%
-160.4%
Q1 25
-1042.1%
Q4 24
-202.0%
Q3 24
-90.7%
Q2 24
-100.9%
Q1 24
-95.7%
Q4 23
-109.2%
Net Margin
IFBD
IFBD
IVF
IVF
Q3 25
-150.5%
Q2 25
-46.7%
-283.6%
Q1 25
-1060.1%
Q4 24
-211.3%
Q3 24
-113.8%
Q2 24
-122.2%
Q1 24
-101.3%
Q4 23
-144.4%
EPS (diluted)
IFBD
IFBD
IVF
IVF
Q3 25
$-0.77
Q2 25
$-0.41
$-13.30
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55
Q4 23
$-59.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IFBD
IFBD
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$698.0K
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$66.7M
$5.8M
Total Assets
$72.4M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IFBD
IFBD
IVF
IVF
Q3 25
Q2 25
$698.0K
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Total Debt
IFBD
IFBD
IVF
IVF
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
IFBD
IFBD
IVF
IVF
Q3 25
$5.8M
Q2 25
$66.7M
$2.6M
Q1 25
$3.3M
Q4 24
$12.7M
Q3 24
$-23.3K
Q2 24
$1.4M
Q1 24
$10.2K
Q4 23
$892.8K
Total Assets
IFBD
IFBD
IVF
IVF
Q3 25
$18.8M
Q2 25
$72.4M
$19.3M
Q1 25
$31.7M
Q4 24
$46.4M
Q3 24
$17.0M
Q2 24
$17.8M
Q1 24
$17.3M
Q4 23
$18.5M
Debt / Equity
IFBD
IFBD
IVF
IVF
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IFBD
IFBD
IVF
IVF
Operating Cash FlowLast quarter
$1.1M
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IFBD
IFBD
IVF
IVF
Q3 25
$-1.8M
Q2 25
$1.1M
$-1.7M
Q1 25
$-3.5M
Q4 24
$-617.4K
Q3 24
$-640.8K
Q2 24
$-1.5M
Q1 24
$-260.6K
Q4 23
$-714.9K
Free Cash Flow
IFBD
IFBD
IVF
IVF
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
Q4 23
FCF Margin
IFBD
IFBD
IVF
IVF
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Q4 23
Capex Intensity
IFBD
IFBD
IVF
IVF
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons